Go to Page # Page of 31

Real World Evidence: Sanofi's Strategy

 Ameet Nathwani MD, Bernard Hamelin MD, Antonio Tataranni MD
  17th-May-2018
Description: The availability of real-world data (RWD) and the use of the appropriate analytical methods create a big opportunity to accelerate/increase patient access to innovative medicines.
Views: 1328
Domain: Medical
Category: Biotech/Pharma
Contributing Organization: Sanofi
 ‐ More of their Presentations
weSRCH App on Apple
Contents:
Real World Evidence:
Sanofi’s strategy
Thursday, March 22, 2018

Agenda
Real World Evidence: Sanofi’s strategy
• 9.05 - 9.20
Why real world data and advanced analytics will transform our industry and medicine
Ameet Nathwani, MD, Executive Vice-President, Chief Medical Officer and Global Head of the
Medical Function
• 9.20 - 9.35
Integration of real world evidence in the deve ... See more

Recent Presentations

Aging: The demographic trend of our time

The matters discussed in this presentation include forward looking statements which are subject to various risks, uncertainties, and other factors that could cause actual results t

...
14 August, 2018

2018 Diagnostic Slide Session Case #8

Healthy, 38-year-old female presented with headache, nausea and photophobia for 3 days. She subsequently developed visual loss and aura in both eyes.

...
13 August, 2018

Committed to Your Health. Every Day

An agile structure offering our customers a wide range of possibilities that meet their requirements in pharmaceuticals, nutraceuticals and dermo-cosmetics.

Mayoly Spindler
10 August, 2018